semaglutide prediabetes weight loss trial progression to diabetes Teaching obesity/weight management this week for our P2s, so here's a post on incretin therapy for loss! 💊 Incretin-based therapy, including the GLP-1 agonists liraglutide and and the GLP-1/GIP dual Prediabetes remission to reduce the

From the time I signed up, I have been kept informed every step of the way

Notably, the extent of weight loss achieved with GLP-1 RA therapy may be directly linked to the degree of reduction in preference for high-calorie foods as semaglutide was associated with reduced cravings for both savory and sugary foods, with decreases in craving scores correlating with greater weight loss (Blundell et al., 2017

Mechanisms hypothesised to underlie blood pressure reduction with tirzepatide include: Weight reduction : Loss of adipose tissue decreases sympathetic nervous system activity, reduces cardiac output, and improves insulin sensitivityall contributing to lower blood pressure Natriuresis : GLP-1 receptor activation may promote sodium excretion through renal effects, though direct evidence for tirzepatide is limited Improved endothelial function : Weight loss and metabolic improvements may enhance vascular health Reduced inflammation : Adipose tissue reduction decreases pro-inflammatory cytokines that may contribute to hypertension It is important to note that whilst the blood pressure reductions are consistent across trials, tirzepatide is not licensed as an antihypertensive agent

If you experience symptoms like muscle weakness, swelling, or severe pain, its important to seek medical advice right away

It stated that the FDA is not seeking to defend its declaration ending the shortage but is only seeking to defend its executive authority